Bastide Le Confort MedicalFRA:1DJ -0.62%71 ROE % is 67.55% as of Dec. 2025, which is 465% above its 10-year median of 11.96. GuruFocus rates FRA:1DJ with a GF Score™ of 71/100 and a GF Value™ of €25.12 (Fairly Valued). The stock has 2 warning signs investors should review. Among 113 Medical Distribution companies, Bastide Le Confort Medical ranks better than 94.69% on this metric.
The historical rank and industry rank for Bastide Le Confort Medical's ROE % or its related term are showing as below:
FRA:1DJ'
s ROE % Range Over the Past 10 Years
Min: -1.08 Med: 11.96 Max: 35.23
Current: 35.23
During the past 13 years, Bastide Le Confort Medical's highest ROE % was 35.23%. The lowest was -1.08%. And the median was 11.96%.
FRA:1DJ's ROE % is ranked better than 94.69% of 113
companies
in the Medical Distribution industry
Industry Median: 7.1
vs FRA:1DJ: 35.23
Bastide Le Confort Medical (FRA:1DJ) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Bastide Le Confort Medical's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical ROE % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's ROE % distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Bastide Le Confort Medical (FRA:1DJ) has a ROE % of 67.55% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Bastide Le Confort Medical and its competitors. This is 465% above median its historical median of 11.96. According to the industry distribution chart, Bastide Le Confort Medical ranks #6 out of 113 companies in the Medical Distribution industry, placing it in the top 5.3%.
Is Bastide Le Confort Medical's ROE % too high?
Bastide Le Confort Medical's current ROE % of 67.55% is 465% above median its 10-year median of 11.96. The Medical Distribution industry median ROE % is 7.10. Bastide Le Confort Medical's value of 67.55% is 851.4% above this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #6 out of 113 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Bastide Le Confort Medical has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's ROE % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #6 out of 113 companies for ROE %. This places Bastide Le Confort Medical in the top 5% of its industry — outperforming the majority of peers. The industry median ROE % is 7.10. Bastide Le Confort Medical's value of 67.55% is 851.4% above this benchmark. While the company's 10-year median is 11.96 vs. the industry median of 7.10, Bastide Le Confort Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Distribution company?
The median ROE % among Medical Distribution companies is 7.10, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current ROE % of 67.55% is 851.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Bastide Le Confort Medical and its competitors. For the Medical Distribution industry, the median ROE % is 7.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current ROE % is 67.55%, which is 465% above median its own 10-year median of 11.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (FRA:1DJ) is currently considered Fairly Valued. The stock's GF Value™ is €25.12, compared to a current price of €24.20 — trading 3.7% below its estimated fair value. The current ROE % is 67.55%, which is 465% above median its 10-year median of 11.96 and 851.4% above the Medical Distribution industry median of 7.10. Bastide Le Confort Medical's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Bastide Le Confort Medical (FRA:1DJ), the current ROE % is 67.55% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (FRA:1DJ) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €24.20 is trading 3.7% below its estimated GF Value™ of €25.12.
GuruFocus considers Bastide Le Confort Medical to be Fairly Valued.
Key valuation signals for FRA:1DJ:
ROE %: 67.55% (465% above median its 10-year median of 11.96)
GF Value™: €25.12 vs. price of €24.20 (3.7% below fair value)
Industry Position: 851.4% above the Medical Distribution median (#6 of 113)
No single metric tells the full story. See the FRA:1DJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
71GF Score
Get the complete analysis for FRA:1DJ
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1DJ has been successfully added to your 
